Partner Content Partner Content 4 Reasons Why You Shouldn't Ignore CDISC Data Standards CDISC standards
Partner Content Partner Content What the Best Clinical Study Build Pros Do (and You Should T... Master Clinical Study Build with ryze!
Partner Content Partner Content The ryze-elluminate integration to maximise automation in cl... The ryze-elluminate integration
Partner Content Partner Content Formedix launches Community Forum to support the clinical tr... Formedix launches the ryze Community Forum
Partner Content Partner Content Formedix Partnered with CDISC to Give Free Access to CDASH-C... Free access to CDASH-Compliant eCRFs
Partner Content Partner Content How the Formedix ryze Visual Define-XML Editor Gives You Fas... Creating Define-XML files has never been easier!
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
